Torrent Pharmaceuticals Expands Losartan Recall

September 24, 2019

Torrent Pharmaceutical has issued a voluntary nationwide recall of Losartan, a drug used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy, and nephropathy in patients with Type 2 diabetes. Testing revealed trace amounts of an unexpected impurity of N-Methylnitrosobutyric acid in three lots of Losartan Potassium Tablets USP and two lots of Losartan Potassium/Hydrochlorothiazide Tablets USP. 

Patients currently taking Losartan are recommended to continue taking the medication and to consult their doctor or pharmacist for advice on alternative treatment. 

Read more about the recall on the FDA website.